HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul J Hagerman Selected Research

Doxycycline (Periostat)

6/2011CGG-repeat length threshold for FMR1 RNA pathogenesis in a cellular model for FXTAS.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul J Hagerman Research Topics

Disease

44Fragile X Tremor Ataxia Syndrome
01/2021 - 01/2004
21Intellectual Disability (Idiocy)
01/2019 - 01/2003
18Fragile X Syndrome (Martin Bell Syndrome)
01/2019 - 10/2003
12Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020 - 07/2004
3Tremor (Tremors)
03/2014 - 05/2003
2Alzheimer Disease (Alzheimer's Disease)
11/2014 - 03/2014
2Disease Progression
08/2011 - 06/2011
2Autistic Disorder (Autism)
08/2011 - 11/2008
2Parkinson Disease (Parkinson's Disease)
02/2009 - 07/2007
2Ataxia (Dyssynergia)
10/2006 - 05/2003
2Movement Disorders (Movement Disorder)
10/2006 - 01/2003
1Neurodevelopmental Disorders
01/2022
1Inflammation (Inflammations)
01/2020
1Autism Spectrum Disorder
06/2014
1Neurobehavioral Manifestations
03/2014
1Protein Deficiency
01/2014
1Mitochondrial Diseases (Mitochondrial Disease)
01/2014
1Hypersensitivity (Allergy)
05/2013
1Friedreich Ataxia (Friedreich's Ataxia)
08/2011
1Gait Ataxia
08/2011
1Neuroblastoma
06/2011
1Brain Diseases (Brain Disorder)
08/2010
1Autoimmune Diseases (Autoimmune Disease)
08/2008
1Myotonic Dystrophy (Dystrophia Myotonica)
04/2007
1Central Nervous System Diseases (CNS Diseases)
01/2007
1Cognitive Dysfunction
10/2006
1Memory Disorders (Memory Loss)
10/2006
1Parkinsonian Disorders (Parkinsonism)
10/2006
1Laminopathies
12/2005
1Mental Disorders (Mental Disorder)
11/2005
1Learning Disabilities (Learning Disability)
01/2004

Drug/Important Bio-Agent (IBA)

29Messenger RNA (mRNA)IBA
09/2014 - 01/2003
15Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2003
125' Untranslated Regions (5' UTR)IBA
01/2019 - 10/2003
12RNA (Ribonucleic Acid)IBA
04/2014 - 07/2004
7ElementsIBA
06/2014 - 12/2003
3UbiquitinIBA
10/2016 - 05/2003
3N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
11/2014 - 05/2013
3Fragile X Mental Retardation ProteinIBA
05/2013 - 01/2003
3Lamin Type A (Lamin A)IBA
01/2010 - 12/2005
3DNA (Deoxyribonucleic Acid)IBA
02/2009 - 07/2007
2ProteomeIBA
01/2021 - 01/2020
2Peptides (Polypeptides)IBA
01/2020 - 01/2019
2Memantine (Namenda)FDA Link
11/2014 - 03/2014
2MicroRNAs (MicroRNA)IBA
09/2014 - 03/2013
2RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2012 - 04/2010
2Mitochondrial Proteins (Mitochondrial Protein)IBA
08/2011 - 08/2010
1phosphoserine aminotransferase (phosphoserine transaminase)IBA
01/2020
1TenascinIBA
01/2020
1enhanced green fluorescent proteinIBA
01/2019
1CalciumIBA
01/2017
1Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)IBA
01/2016
1Glutamic Acid (Glutamate)FDA Link
11/2014
1Biological ProductsIBA
09/2014
1Adenosine Triphosphatases (ATPase)IBA
08/2011
1FrataxinIBA
08/2011
1Aconitate Hydratase (Aconitase)IBA
08/2011
1oligomycin sensitivity-conferring protein (complex V)IBA
08/2011
1IronIBA
08/2011
1ZincIBA
08/2011
1Untranslated Regions (Untranslated Region)IBA
08/2011
1Doxycycline (Periostat)FDA LinkGeneric
06/2011
1NAD (NADH)IBA
08/2010
1Oxygen (Dioxygen)IBA
08/2010
1Adenosine Triphosphate (ATP)IBA
08/2010
1NeurotoxinsIBA
08/2010
1Flavin-Adenine Dinucleotide (FAD)IBA
08/2010
1Crystallins (Crystallin)IBA
08/2008
1Biomarkers (Surrogate Marker)IBA
06/2008
1NestinIBA
01/2005
1CytosineIBA
01/2004
1GuanineIBA
01/2004

Therapy/Procedure

2Therapeutics
09/2012 - 10/2006
1Activities of Daily Living (ADL)
10/2009